I think it is quite remarkable how we as humans have improved in the pharmaceutical and medical fields in the last 100 years. I am sure that we will remain courageous and continue to innovate!
LATEST NEWS AND EVENTS
On September 15th 2022, EMA published new concept papers, explaining current requirements on impurities testing, specifications and the control of DNA-reactive chemicals either partly or fully exclude synthetic peptides and oligonucleotides.
29.09.2022
U.S. Department of Health and Human Services Food and Drug Administration (US FDA) has issued a draft guidance on Computer Software Assurance for Production and Quality System Software on September 13th, 2022.
26.09.2022
Bonn – Universitätsclub
Importance of having principles of good documentation practice implemented in company procedures and day to day operations is evident from the outcome of Health Authority inspections.
22.09.2022
The current version of the chapter is official as of February 1st, 2021. Pharmacopeial Forum, PF 48(3) proposed the revisions with a deadline for submitting comments by July 31st, 2022.
19.09.2022
Today, 2nd September 2022, is the last day for MAHs in Europe to fulfill their responsibility.
02.09.2022
The work plan includes specific activities to achieve an objective as well as routine activities that contribute to the overall strategic objective.
31.08.2022
OUR SERVICES
PHARMACEUTICAL / MEDICAL CONSULTANTS
TEAM OF EXPERTS
Billev Pharma East has a highly educated and dedicated team of experts with many years of international experience in the pharmaceutical industry.
We are providing our present services to our customers on this foundation. Therefore, we offer you scientific solutions with beneficial impact on your business processes to gain competitive advantages.
EXCELLENCE
Billev Pharma East has been recently awarded the “Excellent SME Slovenia” certificate.
This certificate is issued by The Chamber of Commerce and Industry of Slovenia for SMEs with the intention to certify the trustworthiness of a specific company.
It serves as a reward for business excellence and outstanding business record.
Only the top 0.4% of top ranking SME companies can get it.
Do you have a question for us? Contact us and we will be happy to advise you and find the best solution for you together with you!
CONTACT US
We are here for your
questions
Billev farmacija vzhod d.o.o.
Billev Pharma East Ltd.
2022 BILLEV PHARMA EAST
Operation title: BILLEV FARMACIJA VZHOD digitalizacija
Link to the European Cohesion Policy website: www.eu-skladi.si
“The investment is co-funded by the Republic of Slovenia and the European Union from the European Regional Development Fund”. – Read more
Operation title: BILLEV FARMACIJA VZHOD digitalizacija Link to the European Cohesion Policy website: www.eu-skladi.si
“The investment is co-funded by the Republic of Slovenia and the European Union from the European Regional Development Fund.” – Read more
